Edetic acid

1 paper3 findings

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

Labs are independent when their papers share no last author and no institution.

Against: findings that point the other way from most findings on the same outcome.

On aging: the drug’s trials ARN judged to be about aging, of every trial that tests it for any use.

No results posted: trials that ended more than a year ago with no results on ClinicalTrials.gov and no paper in ARN’s record.

Company ties: findings with an author at a company, or from a paper whose competing-interests statement declares ties to one.

1 lab in 1 country

Funders: National Heart, Lung, and Blood Institute and 2 more

Animals1

Outcomes

Calcium deposits

downin Rodentia1

1 study

Edetic acid decreases calcium deposits in Rodentia.
“EDTA chelation therapy removes calcium deposits from arteries in the CKD model”
Reviewin CKD modelarteries
Targeted chelation therapy decreases NLRP3 expression by vascular cells and acts as senomorphic in chronic kidney disorder induced vascular calcification
International journal of immunopathology and pharmacology15 Dec 2025

Latest

1 in 12 months

International Journal of Immunopathology and Pharmacology16 Dec

Targeted chelation therapy decreases NLRP3 expression by vascular cells and acts as senomorphic in chronic kidney disorder induced vascular calcification

Experiments in rodentsVascular calcification

Paper

Edetic acid

Outcomes

Latest

Targeted chelation therapy decreases NLRP3 expression by vascular cells and acts as senomorphic in chronic kidney disorder induced vascular calcification

Related